Myricetin inhibits panel of kinases implicated in tumorigenesis. - GreenMedInfo Summary
Myricetin Inhibits Panel of Kinases Implicated in Tumorigenesis.
Basic Clin Pharmacol Toxicol. 2019 Jan 9. Epub 2019 Jan 9. PMID: 30624861
About 80% of the antineoplastic drugs produced in the last 30 years are of natural origin or their derivatives, evidencing the great contribution of natural products in the development of new drugs (1). Phytochemical constituents of various plants are a source of biomolecules candidates (2), including polyphenols as flavonoids, showing expressive antioxidant (3, 4) and anticancer features (5). Flavonoids constituents are known for their antitumour activity such as inhibition of cell proliferation, adhesion and invasion, cell cycle arrest and apoptosis (6). This article is protected by copyright. All rights reserved.